The effect of COVID 19 vaccination on kidney recipients Background: Nearly one year from the onset of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, safe and effective vaccines began distribution around the world. This study aimed to assess the rate of COVID-19 disease among vaccinated kidney transplant patients and the types of symptoms found within them. As a sample size, 159 cadavers' kidney recipients received two doses of the Sinopharm SARS-CoV-2 vaccine. Results: The mean age of the vaccinated participants was 49.44

The outcome of marginal hearts compared with ideal donors: A single center experience from Iran Introduction: Heart transplantation has been considered as gold standard treatment for patients with end-stage heart failure. This study aimed to assess the survival outcome of marginal donor hearts compared with ideal donors in Iran. Among 93 participants, 75 were categorized as ideal donors (Group A) and 18 were marginal donors (Group B). To observe possible differences among patient

Impacts of COVID-19 Pandemic on Organ donation and transplantation activities in Iran Background: Coronavirus disease 2019 (COVID-19) pandemic has had a great impact on reducing organ transplantation activities. The questionnaire included the numbers of brain death confirmations, family consents, organ recoveries, and transplanted solid organs. Brain death due to head trauma significantly decreased in two time intervals and suicide increased by 14.44% during the COVID-19 pandemic compared to 2018-2019 period. Conclusion: A significant reduction was observed in organ donation and transplantation during COVID-19 pandemic.

Choriocarcinoma transmitted with the transplant: Case Study Choriocarcinoma is a rare kind of cancer that may be either gestational or non-gestational. The goal of this research is to report a case of choriocarcinoma transmission from the donor following kidney donation. A 45-year-old female received a kidney from a 25-year-old brain death referred to the hospital due to a cerebral hemorrhage of non-traumatic origin. She had a successful delivery 48 days before the brain death. The transplant was successfully performed.

Brain death hormone therapy and Graft survival: a systematic review of the literature Method and materials: Randomized clinical trials were reviewed to investigate the effects of hormone therapy on graft survival amongst brain death cases. Conclusions: All in all, results from the present systematic reviews showed that the brain death hormone therapy use does not have a detrimental effect on overall survival organ recipients. Keywords: Brain death, Hormone therapy, Graft survival

COVID-19 Infection in Kidney Transplant Recipients From a Single Center in Iran In this study, our aim was to evaluate the risk factors for increased mortality in deceased donor kidney transplant recipients with COVID-19 at a single center in Iran. Materials and methods: This was a retrospective study in a single center. During the 17-month ongoing COVID19 pandemic in Iran, there were 153 deceased donor kidney recipients at our center with suspected COVID19 symptoms.